North Mississippi Medical Center

Tupelo, Mississippi 38804

7 studies enrolling now · 69 studies all time

What they study most

ASCVD, Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Adult Solid Tumor, Aortic Stenosis, Aortic Valve Insufficiency, Aortic Valve Stenosis, Arthritis, Rheumatoid, Atrial Arrhythmia, Atrial Fibrillation, Atrial Tachycardia, Atrium; Fibrillation

Studies at this site

• Assessment of CCM in HF With Higher Ejection Fraction — Recruiting now
• EVERO Drug-coated Balloon (DCB) Randomized Trial — Recruiting now
• Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
• SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
• The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism — Recruiting now
• The CONFORM Pivotal Trial — Recruiting now
• SPYRAL GEMINI Pilot Study — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels — Recruiting now
• CHAMPION-AF Clinical Trial — Running, not enrolling
• SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
• The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis — Completed
• Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE) — Running, not enrolling
• FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter — Completed
• SIMPLAAFY Clinical Trial — Running, not enrolling
• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Running, not enrolling
• ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE) — Completed
• Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System — Completed
• The Jewel IDE Study — Completed
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• Esprit BTK Post-Approval Study — Running, not enrolling
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF) — Running, not enrolling
• Abbott Atrial Fibrillation Post Approval Study — Running, not enrolling
• DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation — Completed
• SUBLOCADE Long-term Outcomes — Completed
• Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial — Running, not enrolling
• National Cardiogenic Shock Initiative — Completed
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
• Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors — Stopped early
• Abbott Next Generation Drug Eluting Stent 48mm Study — Completed
• LBBAP Data Collection Registry — Completed
• LSI (Lesion Index) Workflow Observational Study — Completed
• Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) — Completed
• TactiFlex Paroxysmal Atrial Fibrillation IDE Trial — Completed
• Absorb IV Randomized Controlled Trial — Completed
• Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions — Completed
• DISRUPT PAD III Observational Study — Completed
• Disrupt CAD III With the Shockwave Coronary IVL System — Completed
• Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients — Status unconfirmed
• SHIELD II Clinical Investigation — Stopped early
• HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt — Completed
• DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry — Status unconfirmed
• Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis — Stopped early
• Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
• ENABLE MRI (Magnetic Resonance Imaging) — Completed
• DyeVert™ Plus Contrast Reduction System Multicenter Observational Study — Completed
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions — Completed